Associated Papers
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.
Ni SC et al.
Blood Cancer Journal, 2025
40389402 (PubMed )
Supplement: 41408_2025_1287_MOESM2_ESM.xlsx › ___1
ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma.
Belani R et al.
Oncogenesis, 2014
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.
Hou HA et al.
Blood, 2012
Select a paper to view details